The state of Texas is accusing major pharmacy benefit managers and drug companies of colluding to raise the cost of insulin.

Lina Khan, chair of the Federal Trade Commission (FTC), would not rule out the possibility of the agency filing an amicus ...

A key hedge fund investor for CVS Health will meet with the company's top brass today in a move that signals a potential ...

The Biden administration could stand to take a firmer hand on hospital price transparency, especially when it is unclear ...

As a community pediatrician with firsthand experience, I've observed an enduring curiosity among parents and caretakers about ...

As the calendar turns to October, the health insurance industry is gearing up for Medicare's annual enrollment period. | As ...

The Centers for Medicare & Medicaid Services (CMS) rolled out guidance Oct. 2 as stakeholders prep for the second round of ...

Another significant legal headache related to star ratings is on the table of the federal government just days before open ...

A new analysis points to troubling trends in the U.S. healthcare market as costs continue to rise but health outcomes are ...

The Biden administration is once again trumpeting the Medicare Prescription Drug Inflation Rebate Program to prove to voters ...

Four of the nation’s leading cancer centers are coming together to work on AI through a newly formed collaborative, the ...

Hospital programs providing at-home acute care are widely appreciated by patients and clinicians, but still don’t have a ...